R&D (Core Technologies and Pipelines)
We design the future of human health
through advanced organoid technology.
Stem Cell and Organoid Culture Platforms
01
- hiPSCs Validated for the Generation of Diverse Organ-Specific Organoids
- Organoid Culture Reagents for Enhanced 3D Self-Organization
- Convenient 3D Tissue Culture & Maintenance
- Ready-to-Use Solutions for Organoid Maintenance
Advancement and Standardization of Human Organoids
02
- Proprietary Technology for Reproducible Organoid Production
- Diverse Human Organoid Models Across Defined Developmental Stages
- Organoid Maturation for Disease Modeling & Repeat Testing
Organoid AI Analysis Technology
03
- Organoid Based Drug Efficacy and Toxicity Assessment
- Quantitative Analysis of Organoid Functional Responses
- AI-Based Organoid Quality Control and Developmental Stage Classification
- Customized Services for Research Objectives
-
organoid model generation(Normal · Disease)
-
AI model training
-
Organoid quality assessment and developmental-stage classification(Performance/Development Stage)
-
Development of efficacy and toxicity evaluation platforms
Regenerative Organoid Research
04
- Patient Specific hiPSC Derived Cardiac Organoids
- Cardiac Organoids with Distinct Differentiation Stages, Maturation Profiles, and Functional Characteristics
- Vascularized Cardiac Organoids Enhancing Cell Survival After Transplantation
R&D
